![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 24, 21115-21118, June 14, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the
Received for publication, April 23, 2002
Inositol 1,4,5-trisphosphate receptor
(IP3R) is a highly controlled calcium
(Ca2+) channel gated by inositol 1,4,5-trisphosphate
(IP3). Multiple regulators modulate
IP3-triggered pore opening by binding to discrete allosteric sites within IP3R. Accordingly we have
postulated that these regulators structurally control ligand
gating behavior; however, no structural evidence has been
available. Here we show that Ca2+, the most pivotal
regulator, induced marked structural changes in the tetrameric
IP3R purified from mouse cerebella. Electron microscopy of
the IP3R particles revealed two distinct structures with
4-fold symmetry: a windmill structure and a square structure. Ca2+ reversibly promoted a transition from the square to
the windmill with relocations of four peripheral
IP3-binding domains, assigned by binding to heparin-gold.
Ca2+-dependent susceptibilities to limited
digestion strongly support the notion that these alterations exist.
Thus, Ca2+ appeared to regulate IP3 gating
activity through the rearrangement of functional domains.
Inositol 1,4,5-trisphosphate receptor
(IP3R)1 is a
tetrameric ion channel that release Ca2+ from intracellular
stores in response to the binding of 1,4,5-trisphosphate (IP3), a second messenger generated by various
extracellular stimuli, neurotransmitters, neuromodulators, hormones,
and lights (1, 2). The IP3R is widely distributed in living
systems and plays pivotal roles in fundamental processes including
fertilization, cellular proliferation and differentiation, cellular
signaling, and vesicle secretion (2). Molecular cloning studies have
revealed that there are three isoforms of IP3R and that
alternative splicing results in several variants of the
IP3R (2). These divergent primary structures of the
IP3R and their differential distributions have been assumed
to award the functional diversity of IP3R by nature.
The most characterized type 1 IP3R (IP3R1), a
predominant type in rodent cerebellar endoplasmic reticulum (ER) and
spine apparatus, plays an integral role in Ca2+ signaling
(3-5) and neural plasticity (6, 7). The protomer of IP3R1,
a 2749-amino acid polypeptide (Mr 313,000),
contains the IP3-binding core (residues 226-578),
membrane-spanning domains (residues 2276-2589), and widespread
allosteric sites for intracellular effector molecules
(Ca2+, calmodulin, and ATP) and for phosphorylation by
protein kinases (cAMP-dependent protein kinase, protein
kinase C, cGMP-dependent protein kinase,
Ca2+/calmodulin-dependent protein kinase II,
and tyrosine kinase) (2). These cumulative allosteric regulations imply
a structural paradigm for global conformational changes within the
higher ordered structure of IP3R1.
Because Ca2+ rigorously determines the channel activity of
IP3R and Ca2+-dependent behavior of
IP3R is considered to be crucial for spatiotemporal organizations of Ca2+ signaling (1, 4), the most important
regulator for IP3R is Ca2+ per se.
Previous functional analysis indicates that a low Ca2+
level acts as an essential coagonist for IP3-gated
Ca2+ release and a high Ca2+ level inversely
acts as a feedback repressor (4, 8, 9) via Ca2+/calmodulin
in part (10). Thereby we assumed that Ca2+ could induce
alterations in conformational states of IP3R1 underlying such dynamic regulations. An investigation of this hypothesis requires
information about structural rearrangements that has heretofore been
unclear because of the structural polymorphism within IP3R
particles, which is partially due to their fragile architectures,
presented by previous electron microscopic studies (11-14). To address
this issue, we improved rapid purification of the IP3R1
channel so that we could use electron microscopic study to visualize
the domain arrangement and to investigate its structural change by
Ca2+.
Purification of IP3R1--
Immunoaffinity
purification of IP3R1 was performed as described previously
(15) with the following modifications. Microsomal membrane (3 mg/ml),
prepared from mouse cerebella, was solubilized in 50 mM
Tris buffer (pH 7.5) containing 1% (w/v) CHAPS, 150 mM KCl, 2 mM dithiothreitol, 200 µM
phenylmethylsulfonyl fluoride, 10 µM pepstatin A, 10 µM leupeptin, 10 µM E-64, and 0.2 mM CaCl2 or 1 mM EDTA. The
solubilized IP3R1 was mixed with pep6Ab-immobilized beads,
incubated at 4 °C, washed, and eluted with 20 µM pep
6. The [3H]-IP3 binding assay was performed
as described previously (11).
Electron Microscopy--
The purified IP3R1 (0.5 µl) was injected into 9.5 µl of 50 mM Tris buffer (pH
7.5) containing 1 mM CaCl2, 1 mM
EDTA, or 1 mM EGTA and incubated for 30 min on ice. For
heparin-gold labeling, purified IP3R1 was mixed with a
5-10-fold molar excess of heparin-gold (Sigma) and incubated for 10 min on ice. An aliquot of the mixture (4 µl) was applied onto
carbon-coated copper grids. Excess solution was removed by filter
paper, and the IP3R1 particles were stained with 2 µl of
1% (w/v) uranyl acetate solution. Dried grids were examined on a JEM
1200 EX transmission electron microscope (JEOL) operated at 80-kV
acceleration voltage. Micrographs were taken at magnifications
ranging from ×25,000 to ×50,000.
Partial Proteolysis--
Partial proteolysis experiments were
carried out in the solution containing IP3R1 and lysyl
endopeptidase (Lys-C). Reaction mixtures were incubated for 30 min at
37 °C. The proteolysis was stopped by heat treatments at 55 °C
for 15 min in the sample buffer including SDS. Proteolytic fragments
were analyzed by discontinuous PAGE (5 or 10% gel) and immunoblotting
using monoclonal antibodies 18A10 and 4C11 (11, 15).
We purified IP3R1 to apparent homogeneity as judged by
gel electrophoresis (Fig. 1A)
from mouse cerebella, which was functionally active as estimated by the
specific activity of maximum binding to IP3 (3 nmol/mg of
protein). The purified IP3R1 was negatively stained and
imaged in a transmission electron microscope. Electron microscopy
explicitly showed two distinct structures in negatively stained
samples. One was a windmill-like structure (Fig. 1B), and
another was a square-shaped structure (Fig. 1C). The
windmill structure contained four segregated radial wings and a central core. Each wing structure appeared to be composed of two domains: a
globular domain, which often exhibited a central spot that was densely
stained, and a constricted segment forming a bridge between the
globular domain and the central core domain. The dimension of the
windmill structure was 31 ± 2 nm (n = 76) from
the tip of one wing to the tip of the opposite wing. The globular
domain in the wing was 8.1 ± 0.8 nm (n = 30) in
diameter, and the central core was 9.8 ± 0.6 nm
(n = 15) in diameter. The shape and dimensions of the
windmill structure are consistent with those previously reported for
IP3R isolated from smooth muscle (12). The dimensions of
the square structure were 19 ± 1 nm (n = 54) on a
side and 24 ± 1 nm (n = 54) on a diagonal line
(Fig. 1C), similar to that of small dense projections in the
smooth ER of rat Purkinje cells (14). Comparison with the dimensions of
ryanodine receptor, another intracellular Ca2+
channel (16), provides support that the projected size of the square
structure in this study is reasonable because of the ratio in the
molecular mass of the protomer. We also found that the IP3R1 particles appeared as other forms, suggesting their
variances of orientation or intrinsic flexibilities.
Our microscopic data revealed two distinct states of the
IP3R1 molecule, leading us to the hypothesis that the
conformation of IP3R1 alters. We tried to capture a
Ca2+-dependent transition between the dual
structures by imaging IP3R1 particles injected into 1 mM CaCl2, 1 mM EDTA, or 1 mM EGTA. Significantly the windmill structures were
abundantly observed in the presence of Ca2+ (Fig.
2A). In contrast, the relative
abundance of windmill structures appeared to decrease in specimens
prepared in solution containing 1 mM EDTA (Fig.
2B). For statistical evaluation, we counted the windmill
particles with more than three identifiable wings and the square forms
with a homologous dimension, which had no wing, on electron
micrographs. Quantitative analysis clearly indicates a significant
difference in the ratio of the two structures in a
Ca2+-dependent manner (Fig. 2C).
Readdition of CaCl2 into the IP3R1 purified
with EDTA restored the windmill configuration, and the number of
windmill structures showed a marked reduction upon readdition of EDTA
into the IP3R1 purified in the presence of
Ca2+, indicating that the structural rearrangements are
reversible (Fig. 2C). IP3 did not induce
significant changes in each state at this resolution, thus the binding
of IP3 may cause a fine structural change to open the
channel.
ACCELERATED PUBLICATION
Two-state Conformational Changes in Inositol 1,4,5-Trisphosphate
Receptor Regulated by Calcium*
§,
**, and


Laboratory for Developmental Neurobiology,
Brain Science Institute, RIKEN (The Institute of Physical and Chemical
Research), 2-1 Hirosawa, Wako, Saitama, 351-0198, Japan, the
¶ Biomolecular Engineering Research Institute (BERI), 6-2-3 Furuedai, Suita, Osaka, 565-0874, Japan, the
Division of
Molecular Neurobiology, Department of Basic Medical Sciences, Institute
of Medical Science, University of Tokyo, 4-6-1, Shirokanedai,
Minato-ku, Tokyo 108-8639, Japan, and the 
Calcium
Oscillation Project, International Cooperative Research Project
(ICORP), Japan Science and Technology Corporation (JST), 3-14-4, Shirokanedai, Minato-ku, Tokyo 108-0071, Japan
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES
![]()
RESULTS AND DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS AND DISCUSSION
REFERENCES

View larger version (64K):
[in a new window]
Fig. 1.
Dual discrete structures of
IP3R1. A, purified IP3R (1.2 µg) on SDS-PAGE (5% gel) stained with Coomassie Brilliant Blue.
Electron microscopic images of negatively stained IP3R1
show a typical top view of a windmill-shaped particle (B)
and a typical top view of a square-shaped particle (C). An
arrow in B indicates a globular domain at the tip of a
radial wing. The scale bar represents 20 nm.

View larger version (88K):
[in a new window]
Fig. 2.
Structural changes in the IP3R1
particle. Electron micrographs of IP3R1 injected into
the solution containing 1 mM CaCl2
(A) or 1 mM EDTA (B). Marked
projections respectively show top or tilted views of windmill particles
(circled) and square particles (boxed).
Bars, 100 nm. C, relative abundance of windmill
and square particles. IP3R1 was purified in 0.2 mM CaCl2 (a), 1 mM EDTA
(b), or neither CaCl2 nor EDTA
(c), and then it was injected into 1 mM
CaCl2, 1 mM EGTA, or 1 mM EDTA.
Ratios were calculated from the identifiable windmill and square
structures counted on electron micrographs. For statistical evaluations
on each condition, 5-11 fields were evaluated resulting in a total of
169-685 molecules indicated at the top of each
bar. The standard deviation was calculated by comparing
different micrographs.
Our findings provide the first evidence of structural alterations in IP3R1 molecules. The structural alteration could account for the polymorphism in IP3R particles presented by previous electron microscopic studies (11-14). The unique architectures and conspicuous conformational changes within the IP3R1 particle differ remarkably from those in the ryanodine receptor particle (17, 18). These differences might result from intrinsic properties of the gating machinery of IP3R1.
To correlate the structural changes in IP3R1 observed by
electron microscopy with changes in solution, we monitored its
sensitivity to limited protease digestion. The patterns of degradative
intermediates were clearly Ca2+-dependent (Fig.
3). In particular, a 38-kDa fragment
detected with 4C11 within the IP3-binding domain was
markedly generated by cleavage in CaCl2 solution; however,
a 48-kDa intermediate and a 38-60-kDa ladder of bands detected with
4C11 were dominantly observed in EDTA solution (Fig. 3B).
Furthermore a C-terminal 130-kDa fragment detected with 18A10 was
abundantly detected by cleavage of purified IP3R1 in
CaCl2 solution compared with 85- and 120-kDa fragments
(Fig. 3B). These results suggest structural changes in
purified IP3R1 rather than a simple acceleration or regulation of proteolysis by Ca2+. The degradation by
contaminant protease, such as Ca2+-activated calpains, was
insignificant because of negligible production of digested proteins
without Lys-C (Fig. 3). In addition, we also investigated the dynamic
property of IP3R1 in crude microsomal membrane. The 38- and
30-kDa fragments detected with 4C11 were evenly precipitated in both
CaCl2 and EDTA solutions; however, these fragments were
more releasable to supernatant fractions in the presence of
CaCl2 than in EDTA (Fig. 3C). We also confirmed the reproducibility of these proteolysis experiments by using 0.5 mM EGTA and 0.2 mM CaCl2 solution.
This heightened ability to release may be related to the structural
changes within IP3R1 embedded in the microsomal membrane.
Taken together, these biochemical data strongly support the presence of
structural alterations in IP3R1.
|
To determine how functional domains are arranged, we used colloidal
gold conjugated with heparin, which is a competitive inhibitor of
IP3 binding (19) and specifically binds to the N-terminal IP3-binding region (20). Heparin-gold particles bound not
only to the windmill structure but also to the square form (Fig.
4, A and B). In the
windmill structure, the gold particles bound to the globular domain of
the radial wings (Fig. 4A). In the square form, the gold
particles attached at the sites close to the corners (Fig.
4B). We assigned these heparin-binding domains to the
N-terminal IP3-binding domain. Our results provide the
first evidence of domain arrangement in quaternary configurations of
the IP3R1 particle. In both states, the distribution of
peripheral IP3-binding domains occurred away from the
center, a plausible Ca2+ gateway, by over 5 nm, suggesting
that a long range allosteric transmission took place underlying the
IP3-gated Ca2+ release.
|
The comparison between dual structures and mapping of heparin-binding sites indicates that the structural transition from square to windmill is caused by the relocation of functional domains. Therefore, we propose a "flapping model" for the large scale rearrangements in IP3R1 (Fig. 4C). The windmill structure may be a consequence of the IP3-binding domain splitting from the channel domain. The dynamic flapping may be mediated by the bridge domain, which may act as a hinge structure. Additionally the digested IP3R retains the assembly of domains under Ca2+-free conditions (21, 22); thus interdomain coupling may also stabilize the more compact square structure. The Ca2+-dependent cleavage sites and releasable regions presented here are candidates for the apparent hinge and interface structures linking between functional domains.
Our findings show that the functional regulator altered the relative locations of IP3-binding and channel domains even if there is no IP3, further emphasizing that the domain arrangement is crucial for the transmission of IP3 binding cues to Ca2+ pores. Two discrete configurations of IP3R1 imply dual relay modes controlling the allosteric transmission. Which of two structures is more active? As it appears to have an advantage for direct transferring of conformational changes by IP3 binding toward the central channel, we cannot exclude the possibility that the compact square form is an active state. Based on single channel analysis, however, high Ca2+ only acts as an activator toward purified IP3R1 (10). Hence it is favorable that the windmill structure is more active. In this case, it is conceivable that the bridge domain presents an effective relay of ligand binding signals. This notion fascinates us as a new type of mechanical control on ligand gating behavior. The three-dimensional structure at much higher resolution will answer our central question on the precise pathway of allosteric transmission from the IP3-binding core to the Ca2+ gateway underlying IP3-gated channel opening.
Ca2+ dependence of IP3R is known to interplay
with the allosteric regulation by ATP (23) and the cooperative gating
by IP3 (24). Thereby the
Ca2+-dependent global conformational changes
may concern primary states for other allosteric ligands. Since
IP3R is known to interact with phosphatidylinositol
4,5-bisphosphate incorporated in the plasma membrane (25), with the
transient receptor potential protein, which is a calcium channel
assumed to be involved in capacitative Ca2+ entry (26), and
with the Homer protein linking with metabotropic glutamate
receptor involved in neural plasticity (27), it is interesting to study
how the dramatic conformational change of IP3R1 alters the
association with these signaling molecules. Our novel model for
structural rearrangements and the methodology presented here should be
useful for understanding of the further biological significance of
structural plasticity within IP3R1 in neural systems.
| |
ACKNOWLEDGEMENTS |
|---|
We thank A. Terauchi (JST) for excellent technical assistance; Y. Kimura (BERI) and H. Sagara (Tokyo University) for discussion about electron microscopy; A. Mizutani (RIKEN) for support in protein purification and for biochemical advice; S. Ohmi (Tokyo University) for peptide synthesis; and A. Takahashi (RIKEN) for 18A10 and 4C11.
| |
FOOTNOTES |
|---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ To whom correspondence should be addressed. Tel.: 81-3-5449-5320; Fax: 81-3-5449-5420; E-mail: hamada@ims.u-tokyo.ac.jp.
** Present address: Laboratory of Vertebrate Developmental Neurogenetics, The Rockefeller University, 1230 York Ave., New York, NY 10021.
Published, JBC Papers in Press, April 29, 2002, DOI 10.1074/jbc.C200244200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: IP3R, inositol 1,4,5-trisphosphate receptor; IP3, inositol 1,4,5-trisphosphate; IP3R1, type 1 IP3R; ER, endoplasmic reticulum; CHAPS, 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate; Lys-C, lysyl endopeptidase.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Berrige, M. J., and Irvine, R. F. (1989) Nature 341, 197-205[CrossRef][Medline] [Order article via Infotrieve] |
| 2. | Furuichi, T., Michikawa, T., and Mikoshiba, K. (1999) in Calcium as a Cellular Regulator (Carafoli, E. , and Klee, C., eds) , pp. 200-248, Oxford University Press, New York |
| 3. |
Miyazaki, S.,
Yuzaki, M.,
Nakada, K.,
Shirakawa, H.,
Nakanishi, S.,
Nakade, S.,
and Mikoshiba, K.
(1992)
Science
257,
251-255 |
| 4. | Miyakawa, T., Mizushima, A., Hirose, K., Yamazawa, T., Bezprozvanny, I., Kurosaki, T., and Iino, M. (2001) EMBO J. 20, 1674-1680[CrossRef][Medline] [Order article via Infotrieve] |
| 5. |
Street, V. A.,
Bosma, M. M.,
Demas, V. P.,
Regan, M. R.,
Lin, D. D.,
Robinson, L. C.,
Agnew, W. S.,
and Tempel, B. L.
(1997)
J. Neurosci.
17,
635-645 |
| 6. |
Inoue, T.,
Kato, K.,
Kohda, K.,
and Mikoshiba, K.
(1998)
J. Neurosci.
18,
5366-5373 |
| 7. | Miyata, M., Finch, E. A., Khiroug, L., Hashimoto, K., Hayasaka, S., Oda, S., Inouye, M., Takagishi, Y., Augustine, G. J., and Kano, M. (2000) Neuron 28, 233-244[CrossRef][Medline] [Order article via Infotrieve] |
| 8. |
Finch, E. A.,
Turner, T. J.,
and Goldin, S. M.
(1991)
Science
252,
443-446 |
| 9. | Bezprozvanny, I., Watras, J., and Ehrlich, B. E. (1991) Nature 351, 751-754[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Michikawa, T., Hirota, J., Kawano, S., Hiraoka, M., Yamada, M., Furuichi, T., and Mikoshiba, K. (1999) Neuron 23, 799-808[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Maeda, N., Niinobe, M., and Mikoshiba, K. (1990) EMBO J. 9, 61-67[Medline] [Order article via Infotrieve] |
| 12. |
Chadwick, C. C.,
Saito, A.,
and Fleischer, S.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
2132-2136 |
| 13. | Katayama, E., Funahashi, H., Michikawa, T., Shiraishi, T., Ikemoto, T., Iino, M., and Mikoshiba, K. (1996) EMBO J. 15, 4844-4851[Medline] [Order article via Infotrieve] |
| 14. | Kanaseki, T., Ikeuch, Y., and Tashiro, Y. (1998) Cell Struct. Funct. 23, 373-387[Medline] [Order article via Infotrieve] |
| 15. |
Nakade, S.,
Rhee, S. K.,
Hamanaka, H.,
and Mikoshiba, K.
(1994)
J. Biol. Chem.
269,
6735-6742 |
| 16. | Lai, F. A., Erickson, H. P., Rousseau, E., and Liu, Q. (1988) Nature 331, 315-319[CrossRef][Medline] [Order article via Infotrieve] |
| 17. | Orlova, E. V., Serysheva, I. I., van Heel, M., Hamilton, S. L., and Chiu, W. (1996) Nat. Struct. Biol. 3, 547-552[CrossRef][Medline] [Order article via Infotrieve] |
| 18. |
Sharma, M. R.,
Jeyakumar, L. H.,
Fleischer, S.,
and Wagenknecht, T.
(2000)
J. Biol. Chem.
275,
9485-9491 |
| 19. |
Ghosh, T. K.,
Eis, P. S.,
Mullaney, J. M.,
Ebert, C. L.,
and Gill, D. L.
(1988)
J. Biol. Chem.
263,
11075-11079 |
| 20. |
Miyawaki, A.,
Furuichi, T.,
Ryou, Y.,
Yoshikawa, S.,
Nakagawa, T.,
Saitoh, T.,
and Mikoshiba, K.
(1991)
Proc. Natl. Acad. Sci. U. S. A.
88,
4911-4915 |
| 21. |
Yoshikawa, F.,
Iwasaki, H.,
Michikawa, T.,
Furuichi, T.,
and Mikoshiba, K.
(1999)
J. Biol. Chem.
274,
316-327 |
| 22. | Boehning, D., and Joseph, S. K. (2000) EMBO J. 19, 5450-5459[CrossRef][Medline] [Order article via Infotrieve] |
| 23. |
Thrower, E. C.,
Mobasheri, H.,
Dargan, S.,
Marius, P.,
Lea, E. J. A.,
and Dawson, A. P.
(2000)
J. Biol. Chem.
275,
36049-36055 |
| 24. |
Missiaen, L., De,
Smedt, H.,
Parys, J. B.,
Sienaert, I.,
Vanlingen, S.,
and Casteels, R.
(1996)
J. Biol. Chem.
271,
12287-12293 |
| 25. |
Lupu, V. D.,
Kaznacheyeva, E.,
Krishna, U. M.,
Falck, J. R.,
and Bezprozvanny, I.
(1998)
J. Biol. Chem.
273,
14067-14070 |
| 26. |
Boulay, G.,
Brown, D. M.,
Qin, N.,
Jiang, M.,
Dietrich, A.,
Zhu, M. X.,
Chen, Z.,
Birnbaumer, M.,
Mikoshiba, K.,
and Birnbaumer, L.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
14955-14960 |
| 27. | Tu, J. C., Xiao, B., Yuan, J. P., Lanahan, A. A., Leoffert, K., Li, M., Linden, D. J., and Worley, P. F. (1998) Neuron 21, 717-726[CrossRef][Medline] [Order article via Infotrieve] |
This article has been cited by other articles:
![]() |
M. J. Betzenhauser, L. E. Wagner II, M. Iwai, T. Michikawa, K. Mikoshiba, and D. I. Yule ATP Modulation of Ca2+ Release by Type-2 and Type-3 Inositol (1, 4, 5)-Triphosphate Receptors: DIFFERING ATP SENSITIVITIES AND MOLECULAR DETERMINANTS OF ACTION J. Biol. Chem., August 1, 2008; 283(31): 21579 - 21587. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. K. Foskett, C. White, K.-H. Cheung, and D.-O. D. Mak Inositol Trisphosphate Receptor Ca2+ Release Channels Physiol Rev, April 1, 2007; 87(2): 593 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Baran Gating Mechanisms of the Type-1 Inositol Trisphosphate Receptor Biophys. J., August 1, 2005; 89(2): 979 - 998. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Laporte, A. Hui, and I. Laher Pharmacological Modulation of Sarcoplasmic Reticulum Function in Smooth Muscle Pharmacol. Rev., December 1, 2004; 56(4): 439 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Kasri, G. Bultynck, J. Smyth, K. Szlufcik, J. B. Parys, G. Callewaert, L. Missiaen, R. A. Fissore, K. Mikoshiba, and H. de Smedt The N-terminal Ca2+-Independent Calmodulin-Binding Site on the Inositol 1,4,5-trisphosphate Receptor Is Responsible for Calmodulin Inhibition, Even Though This Inhibition Requires Ca2+ Mol. Pharmacol., August 1, 2004; 66(2): 276 - 284. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. SPAT and L. HUNYADY Control of Aldosterone Secretion: A Model for Convergence in Cellular Signaling Pathways Physiol Rev, April 1, 2004; 84(2): 489 - 539. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Hamada, A. Terauchi, and K. Mikoshiba Three-dimensional Rearrangements within Inositol 1,4,5-Trisphosphate Receptor by Calcium J. Biol. Chem., December 26, 2003; 278(52): 52881 - 52889. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Webster, S. Tiwari, A. M. Weissman, and R. J. H. Wojcikiewicz Inositol 1,4,5-Trisphosphate Receptor Ubiquitination Is Mediated by Mammalian Ubc7, a Component of the Endoplasmic Reticulum-associated Degradation Pathway, and Is Inhibited by Chelation of Intracellular Zn2+ J. Biol. Chem., October 3, 2003; 278(40): 38238 - 38246. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. I. Serysheva, D. J. Bare, S. J. Ludtke, C. S. Kettlun, W. Chiu, and G. A. Mignery Structure of the Type 1 Inositol 1,4,5-Trisphosphate Receptor Revealed by Electron Cryomicroscopy J. Biol. Chem., June 6, 2003; 278(24): 21319 - 21322. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Uchida, H. Miyauchi, T. Furuichi, T. Michikawa, and K. Mikoshiba Critical Regions for Activation Gating of the Inositol 1,4,5-Trisphosphate Receptor J. Biol. Chem., May 2, 2003; 278(19): 16551 - 16560. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ramos, W. Jung, J. Ramos-Franco, G. A. Mignery, and M. Fill Single Channel Function of Inositol 1,4,5-trisphosphate Receptor Type-1 and -2 Isoform Domain-Swap Chimeras J. Gen. Physiol., April 28, 2003; 121(5): 399 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. A. da Fonseca, S. A. Morris, E. P. Nerou, C. W. Taylor, and E. P. Morris Domain organization of the type 1 inositol 1,4,5-trisphosphate receptor as revealed by single-particle analysis PNAS, April 1, 2003; 100(7): 3936 - 3941. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Adler, N. R. Gough, and L. B. Ray 2002: Signaling Breakthroughs of the Year Sci. Signal., January 7, 2003; 2003(164): eg1 - eg1. [Full Text] [PDF] |
||||
![]() |
A. M. Riley, S. A. Morris, E. P Nerou, V. Correa, B. V. L. Potter, and C. W. Taylor Interactions of Inositol 1,4,5-Trisphosphate (IP3) Receptors with Synthetic Poly(ethylene glycol)-linked Dimers of IP3 Suggest Close Spacing of the IP3-binding Sites J. Biol. Chem., October 18, 2002; 277(43): 40290 - 40295. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |